Skip Navigation



NDT Advance Access published online on March 27, 2008

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfn149
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/9/2834    most recent
gfn149v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yang, X.
Right arrow Articles by Chan, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, X.
Right arrow Articles by Chan, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Effects of albuminuria and renal dysfunction on development of dyslipidaemia in type 2 diabetes—the Hong Kong Diabetes Registry

Xilin Yang1, Wing Yee So1, Ronald Ma1, Gary Ko1,2, Alice Kong1,3, Christopher Lam4, Chung Shun Ho4, Clive Cockram1, Chun-Chung Chow1, Peter Tong1 and Juliana Chan1

1 Department of Medicine and Therapeutics 2 Hong Kong Institute of Diabetes and Obesity 3 Li Ka Shing Institute of Health Sciences 4 Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China

Correspondence and offprint requests to: Wing Yee So, 9/F Department of Medicine and Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China. Tel: +852-2632-3138; Fax: +852-2632-3108; E-mail: wingyeeso{at}cuhk.edu.hk



  Abstract

Background. It is uncertain whether albuminuria precedes the future development of high total cholesterol (TC > 6.2 mmol/l) and high LDL-C (>4.1 mmol/l) while renal dysfunction precedes the future development of low HDL-C (<0.9 mmol/l) in type 2 diabetes.

Methods. A prospective cohort of 2761 type 2 diabetic patients without significant dyslipidaemia and having at least one measurement of TC, LDL-C and HDL-C during 2.8 years of follow-up was analysed. The spline Cox regression model was used to derive hazard ratio (HR) curves of the spot urinary albumin:creatinine ratio (ACR) and the estimated glomerular filtration rate (eGFR) for dyslipidaemia, followed by standard Cox models to confirm the findings from the HR curves.

Results. Seven percent of the cohort developed high TC, 4.6% developed high LDL-C and 5.7% developed low HDL-C during follow-up. In multivariate analysis, the HR of ACR for high TC and high LDL-C increased rapidly and linearly from zero with no apparent threshold. Patients with macroalbuminuria (ACR ≥25 mg/mmol) were, respectively, 1.6- and 2.4 folds more likely to develop high TC and high LDL-C than those with normoalbuminuria at baseline. The HR of eGFR for low HDL-C increased rapidly with declining eGFR at <110 ml/min/ 1.73 m2. Subjects with eGFR <60 ml/min/1.73 m2 and ≥60–<110 ml/min/1.73 m2, respectively, had 3.0-fold and 1.8-fold risks of low HDL-C compared to those with eGFR ≥110–<140 ml/min/1.73 m2.

Conclusions. In type 2 diabetes, macroalbumninuria predicts high TC and high LDL-C, while reduced renal function, even within normal range, predicts low HDL-C.

Keywords: albuminuria; Chinese; dyslipidaemia; Hong Kong; renal function

Received for publication: 7.12.07
Accepted in revised form: 25. 2.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.